Related Experiment Video
Updated: Feb 6, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies
1ToolGen, Inc., Seoul 08501, Korea.
Abstract:
Chimeric antigen receptor (CAR) T-cell therapy, an emerging immunotherapy, has demonstrated promising clinical results in hematological malignancies including B-cell malignancies. However, accessibility to this transformative medicine is highly limited due to the complex process of manufacturing, limited options for target antigens, and insufficient anti-tumor responses against solid tumors. Advances in gene-editing technologies, such as the development of Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9), have provided novel engineering strategies to address these limitations. Development of next-generation CAR-T cells using gene-editing technologies would enhance the therapeutic potential of CAR-T cell treatment for both hematologic and solid tumors. Here we summarize the unmet medical needs of current CAR-T cell therapies and gene-editing strategies to resolve these challenges as well as safety concerns of gene-edited CAR-T therapies.
Insights
Chimeric antigen receptor (CAR) T-cell therapy shows promise but faces accessibility and efficacy challenges. Gene-editing technologies offer new strategies to enhance CAR-T cell therapies for both blood cancers and solid tumors.
Area of Science:
- Immunotherapy
- Oncology
- Biotechnology
Background:
- Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for hematological malignancies.
- Current limitations include manufacturing complexity, limited target antigens, and poor efficacy against solid tumors.
Purpose of the Study:
- To summarize unmet needs in current CAR T-cell therapies.
- To explore gene-editing strategies for next-generation CAR-T cells.
- To discuss safety concerns of gene-edited CAR-T therapies.
Main Methods:
- Review of current CAR T-cell therapy limitations.
- Analysis of gene-editing technologies (ZFNs, TALENs, CRISPR/Cas9) for CAR-T cell engineering.
- Discussion of safety considerations for enhanced CAR-T therapies.
Main Results:
- Gene-editing technologies provide novel strategies to overcome CAR T-cell therapy limitations.
- Next-generation CAR-T cells engineered with gene editing show enhanced therapeutic potential.
- Addressing safety concerns is crucial for clinical translation.
Conclusions:
- Gene editing offers a pathway to improve CAR T-cell therapy accessibility and efficacy.
- Enhanced CAR-T cell therapies hold potential for treating both hematologic and solid tumors.
- Further research is needed to ensure the safety and effectiveness of gene-edited CAR-T therapies.
Related Concept Videos
Gene Therapy
RNA Editing
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Cell Specific Gene Expression
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...

